News Category
MindWave Innovations is building an interconnected blockchain ecosystem to provide infrastructure for institutional digital finance, emphasizing valid...
HWAL Inc. leverages a $480 million music catalog and innovative partnerships to preserve and monetize entertainment assets across traditional and digi...
Stewards, Inc. (NASDAQ: SWRD) has received approval to uplist its common stock to the Nasdaq Capital Market, a move that could enhance liquidity and i...
FingerMotion Inc. (NASDAQ: FNGR) reported a stronger cash position and a nearly 30% reduction in monthly cash burn within the first 30 days under new ...
Regentis Biomaterials reported first half 2026 financial results, highlighted progress in its Phase III GelrinC trial, and announced a 400% production...
Renewable energy and battery storage can address longstanding grid challenges by adding backup capacity without new power plants, as demonstrated in T...
Saudi Arabia's rapid crypto expansion is driving the MENA region toward $350 billion in transactions, signaling a major shift that could attract globa...
Reports that OpenAI agents hacked a German website highlight the urgent need for robust oversight and security measures as AI systems grow more autono...
Greenland Mines has completed its acquisition of the Sarfartoq rare earths project, marking the start of a catalyst-rich period that includes active d...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS represents a potential paradigm shift in multiple sclerosis treatment by targeting m...
TransCode Therapeutics has named John Tattory as interim CFO after Tom Fitzgerald's retirement, bringing extensive financial leadership to the clinica...
Earth Science Tech Inc. reported significant revenue growth and improved financial health, demonstrating the success of its vertically integrated B2B-...
Perpetuals.com and the European Institute of Management have formed a joint research group to develop AI-powered trading models, leveraging proprietar...
Trilogy Metals' inclusion in the 2026 TSX30 highlights its exceptional stock performance and the strategic value of its Arctic Project for American cr...
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial in multiple sclerosis, potentially ...
Quantum BioPharma's FDA clearance to launch a phase 2 trial of Lucid-MS, a first-in-class myelin-repair therapy for multiple sclerosis, represents a h...
Quantum BioPharma receives FDA clearance to launch a phase 2 trial of Lucid-MS, a first-in-class multiple sclerosis drug designed to protect and rebui...
American Fusion Inc. (OTC: AMFN) is developing its Texatron Fusion Engine to address surging electricity demand from AI and data centers, but the tech...
Helus Pharma's CEO will present at the Morgan Stanley Global Healthcare Conference, highlighting the company's advanced clinical programs for depressi...
Rezolve Ai's CEO will participate in a major investment conference and host an Investor Day to showcase its agentic commerce and AI infrastructure, si...
Lahontan Gold Corp. has named Billy Choi as its new chief financial officer, a strategic move aimed at strengthening financial leadership as the compa...
American Fusion Inc. has moved its Texatron fusion program into active testing, achieving peak confinement pressures of 100,000 atmospheres and attrac...
American Fusion Inc. has transitioned its Texatron fusion program from prototype development to active testing, reporting peak confinement pressures o...
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, is moving toward a Phase 2 trial for multiple sclerosis following FDA clea...
Forward Industries calls on SkyAI shareholders to oppose the 2026 Equity Incentive Plan and withhold votes from all director nominees, citing governan...
Greenland Mines Ltd. completes acquisition of Sarfartoq rare earths project, shifting from a single palladium-gold-platinum focus to a balanced portfo...
Kairos Pharma's CEO will present at the H.C. Wainwright conference, underscoring the company's innovative approach to tackling cancer drug resistance ...
Fairchild Gold has contracted TerraEye to conduct satellite-based spectral and structural analysis across its Golden Arrow project in Nevada, aiming t...
The sharp decline in U.S. electric vehicle sales following the expiration of a key federal tax credit suggests EVs may struggle to move beyond niche s...
Quantum BioPharma's FDA clearance for Lucid-MS Phase 2 trial marks a pivotal milestone in developing a first-in-class therapy that could repair myelin...
Quantum BioPharma's Lucid-MS, a first-in-class myelin-protective multiple sclerosis drug candidate, has received FDA clearance to begin a Phase 2 tria...
Helus Pharma's CEO participation in a major investment conference underscores the company's advancing clinical pipeline for mental health treatments.
Mobix Labs announces its first production order for F-16 components, highlighting its expanding role across major U.S. fighter programs and the growin...
SS Innovations International is rapidly expanding its SSi Mantra surgical robotic system beyond India, with strong revenue growth and international in...
Mobix Labs receives its first production order for F-16 components, reinforcing its presence across major U.S. fighter programs and highlighting growt...
Faraday Future's participation in the Moody Capital conference highlights its strategic shift toward embodied AI robotics, signaling potential growth ...
Cyabra's participation in the Moody Capital Solutions Disruptive Growth & Life Sciences Conference highlights its AI-driven defense against disinforma...
Impala Platinum's enhanced dividend payout highlights the robust recovery in platinum group metals prices, prompting investors to watch how other prod...
LaFleur Minerals is poised to transition from mill recommissioning to gold production at its fully permitted Beacon Gold Mill, leveraging nearby Swans...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials for multiple sclerosis marks a pivotal step toward a targeted therapy that c...
Quantum BioPharma received FDA clearance to begin a Phase 2 trial of Lucid-MS in multiple sclerosis, marking a key step for a first-in-class candidate...
The 2026 Moody Capital Disruptive Growth & Life Sciences Conference arrives as small-cap life sciences and AI-related infrastructure sectors face heig...
The LGL Group's participation in the Moody Capital Solutions conference highlights its strategic focus on critical technologies and disciplined capita...
Interlink Electronics' participation in the Moody Capital conference underscores its growth strategy and expanding presence in medical, automotive, an...
Focus Universal Inc. announced the exercise of warrants for $3.72 million, boosting its cash reserves to accelerate development of its IoT and 5G prod...
Shenzhen HQVT Technology's interim results reveal 84.5% revenue growth driven by multispectral AI model services, and its upcoming Stock Connect inclu...
Focus Universal Inc. announced the exercise of warrants for approximately $3.7 million, which will fund its ongoing development of IoT and 5G technolo...
VERAXA Biotech's appointment of seasoned financial executive Raju Willener as CFO signals a strategic move to strengthen its capital markets position ...
